CA2583079A1 - Methods using glycosaminoglycans for the treatment of kidney disease - Google Patents
Methods using glycosaminoglycans for the treatment of kidney disease Download PDFInfo
- Publication number
- CA2583079A1 CA2583079A1 CA002583079A CA2583079A CA2583079A1 CA 2583079 A1 CA2583079 A1 CA 2583079A1 CA 002583079 A CA002583079 A CA 002583079A CA 2583079 A CA2583079 A CA 2583079A CA 2583079 A1 CA2583079 A1 CA 2583079A1
- Authority
- CA
- Canada
- Prior art keywords
- day
- composition
- amount
- administered
- sulodexide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61547204P | 2004-10-01 | 2004-10-01 | |
US60/615,472 | 2004-10-01 | ||
US62233204P | 2004-10-26 | 2004-10-26 | |
US60/622,332 | 2004-10-26 | ||
PCT/US2005/035790 WO2006039709A1 (en) | 2004-10-01 | 2005-10-03 | Methods using glycosaminoglycans for the treatment of kidney disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2583079A1 true CA2583079A1 (en) | 2006-04-13 |
Family
ID=36142893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002583079A Abandoned CA2583079A1 (en) | 2004-10-01 | 2005-10-03 | Methods using glycosaminoglycans for the treatment of kidney disease |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1804810A4 (de) |
JP (1) | JP2008515807A (de) |
AU (1) | AU2005292202A1 (de) |
CA (1) | CA2583079A1 (de) |
IL (1) | IL182353A0 (de) |
WO (1) | WO2006039709A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2616230A1 (en) * | 2005-07-22 | 2007-02-01 | Trf Pharma, Inc. | Method for treating sickle cell disease and sickle cell disease sequelae |
MX2008008213A (es) | 2005-12-22 | 2008-09-03 | Neurochem Int Ltd | Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias. |
EP2765984B1 (de) * | 2011-10-11 | 2019-07-31 | HemaFlo Therapeutics, Inc. | Verfahren zur behandlung einer akuten nierenverletzung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1245907B (it) * | 1991-05-17 | 1994-10-25 | Alfa Wassermann Spa | Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica. |
IT1270846B (it) * | 1993-05-10 | 1997-05-13 | Alfa Wassermann Spa | Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica. |
US20010005720A1 (en) * | 1995-06-07 | 2001-06-28 | U.S.A. As Represented By The Secretary Department Of Health And Human Services | Method of treating chronic progressive vascular scarring diseases |
US20030013680A1 (en) * | 2001-06-12 | 2003-01-16 | Keryx | Methods using glycosaminoglycans for the treatment of nephropathy |
-
2005
- 2005-10-03 JP JP2007534903A patent/JP2008515807A/ja active Pending
- 2005-10-03 WO PCT/US2005/035790 patent/WO2006039709A1/en active Application Filing
- 2005-10-03 AU AU2005292202A patent/AU2005292202A1/en not_active Abandoned
- 2005-10-03 EP EP05807269A patent/EP1804810A4/de not_active Withdrawn
- 2005-10-03 CA CA002583079A patent/CA2583079A1/en not_active Abandoned
-
2007
- 2007-04-01 IL IL182353A patent/IL182353A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1804810A1 (de) | 2007-07-11 |
AU2005292202A1 (en) | 2006-04-13 |
EP1804810A4 (de) | 2008-02-27 |
JP2008515807A (ja) | 2008-05-15 |
IL182353A0 (en) | 2008-04-13 |
WO2006039709A1 (en) | 2006-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1392329B1 (de) | Verwendung von sulodexid zur behandlung von reizdarm | |
US20080070862A1 (en) | Methods using glycosaminoglycans for the treatment of nephropathy | |
AU2002304265A1 (en) | Use of sulodexide for the treatment of inflammatory bowel disease | |
EP2371371B1 (de) | Zusammensetzung zur prävention von adhäsion | |
US20100266709A1 (en) | Compositions and Methods for Treating Burns | |
US7604797B2 (en) | Compositions and methods for treating burns | |
CA2365767A1 (en) | Angiogenesis inhibition | |
EP3474897B1 (de) | Cilastatin zur verwendung bei der behandlung von sepsis | |
JP2001519392A (ja) | シクロスポリンおよびタクロリムスによって起こる腎臓毒の防止方法 | |
CA2583079A1 (en) | Methods using glycosaminoglycans for the treatment of kidney disease | |
JP2000309538A (ja) | 子癇前症および関連疾患の新規治療法 | |
US20240050464A1 (en) | Therapeutic Composition and Methods | |
CN114727976A (zh) | PPAR-δ激动剂在肾脏疾病治疗中的用途 | |
KR100815287B1 (ko) | 당뇨성 신장병의 치료에 슐로덱사이드를 사용하는 방법 및조성물 | |
US20070173479A1 (en) | Methods Using Sulodexide for the Treatment of Bladder Disease | |
CA2502510A1 (en) | Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor | |
JP2006519817A (ja) | 新しい医薬 | |
Milani | Sulodexide: Review of recent clinical efficacy data | |
AU2002311591A1 (en) | Use of glycosaminoglycans for the treatment of HIV-associated nephropathy | |
CH702779B1 (fr) | Utilisation de polysulfate de pentosan sodique dans la préparation d'un médicament pour le traitement de la néphropathie diabétique. | |
WO2008060567A1 (en) | Glycosaminoglycan formulations in the treatment of vascular disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20090903 |